Home › Research › Risk factors
Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial
Hooper E, Simkin Z, Abrams H, Camacho E, Charalambous AP, Collin F, Constantinidou F, Dawes P et al.. Journal of the American Geriatrics Society, 2019-04-29
Topic: Risk, prevention and care in population studies
Plain-language summary
Objectives People with dementia (PwD) frequently experience hearing and vision impairment that is underrecognized and undertreated, resulting in reduced quality of life. Managing these impairments may be an important strategy to improve outcomes in PwD. Our objective was to field-trial a multifaceted sensory intervention (SI) to enhance hearing and vision in PwD. Design An international single-arm open-label feasibility, acceptability, and tolerability study. Setting Home-based setting in the United Kingdom, France, and Cyprus. Participants Adults aged 60 years and older with mild-to-moderate dementia and uncorrected or suboptimally corrected hearing and/or vision impairment, and their study partners (n = 19 dyads). Intervention A sensory intervention (SI), comprising assessment of hearing and vision, fitting of corrective devices (glasses, hearing aids), and home-based support from a sensory support therapist for device adherence and maintenance, communication training, referral to support services, environmental sensory modification, and optimization of social inclusion. Measurements Ratings of study procedure feasibility, and intervention acceptability/tolerability, ascertained through questionnaires, participant diaries, therapist logbooks, and semistructured interviews. Results We successfully delivered all intervention components, and these were received and enacted as intended in all those who completed the intervention. No serious adverse events were reported. Acceptability (ie, understanding, motivation, sense of achievement) and tolerability (ie, effort, fatigue) ratings of the intervention were within a priori target ranges. We met recruitment and retention (93.8%) targets in two of the three sites. Participants completed more than 95% of diary entries, representing minimal missing data. Delays in the logistics circuit for the assessment and delivery of hearing aids and glasses were identified, requiring modification. The need for minor modifications to some outcome measures and the inclusion criteria were identified. Conclusion This is the first study combining home-based hearing and vision remediation in PwD. The positive feasibility, acceptability, and tolerability findings suggest that a full-scale efficacy trial, with certain modifications, is achievable.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hooper, E., Simkin, Z., Abrams, H., Camacho, E., Charalambous, A. P., Collin, F., et al. (2019). Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.15936
Vancouver
Hooper E, Simkin Z, Abrams H, Camacho E, Charalambous AP, Collin F, et al. Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial. Journal of the American Geriatrics Society. 2019. doi:10.1111/jgs.15936. PMID: 31034588.
BibTeX
@article{hooper2019-31034588,
author = {Hooper, E. and Simkin, Z. and Abrams, H. and Camacho, E. and Charalambous, A. P. and Collin, F. and Constantinidou, F. and Dawes, P. and others},
title = {{Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial}},
journal = {Journal of the American Geriatrics Society},
year = {2019},
doi = {10.1111/jgs.15936},
pmid = {31034588},
url = {https://doi.org/10.1111/jgs.15936}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results We successfully delivered all intervention components, and these were received and enacted as intended in all those who completed the intervention.
- The positive feasibility, acceptability, and tolerability findings suggest that a full-scale efficacy trial, with certain modifications, is achievable.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Study designopen-label trial
- Participants19
- Effect size93.8%
- Evidence strengthLow
How this study scored 49/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record and institution's track record, so those were left out: it earned 30 of the 61 points we could judge it on, which is 49 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the American Geriatrics Society) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | Design recorded as “open-label trial”, which our rubric does not rank (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2019 — within 10 year(s) of the newest study here |
| Sample size | 1 / 4 | 19 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 2 / 3 | PubMed indexes it as a multicentre study |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 31034588) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 30 / 61 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 30 of the 61 points we could judge it on is 49 out of 100. |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.